Hubei Maitong Innovative Pharmaceutical Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Hubei Maitong Innovative Pharmaceutical Co., Ltd. - overview
Established
2025
Location
Huangshi, Hubei, China
Primary Industry
Pharmaceuticals
About
Based in Huangshi, China and founded in 2025, Hubei Maitong Innovative Pharmaceutical Co. , Ltd. is a pharmaceutical company involved in the research and development of targeted anti-tumor drugs. In December 2025, Hubei Maitong Innovative Pharmaceutical Co.
, Ltd. closed angel funding from new investor Hubei High Technology. Hubei Maitong Innovative Pharmaceutical Co. , Ltd.
focuses on the development of small molecule targeted drugs against tumor metabolism-related enzymes. The company generates revenue from developing targeted anti-tumor drugs. The angel financing will be primarily used by the company to advance preclinical research on its early-stage drug development pipeline and to build its team.
Current Investors
Hubei High Technology
Primary Industry
Pharmaceuticals
Sub Industries
Oncology/Cancer Treatment, Pharmaceutical Research & Development
Verticals
HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.